[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

SK9442001A3 - Imidazo[4,5-c]-pyridine-4-on-derivatives, process for the preparation thereof, use thereof and pharmaceutical composition comprising same - Google Patents

Imidazo[4,5-c]-pyridine-4-on-derivatives, process for the preparation thereof, use thereof and pharmaceutical composition comprising same Download PDF

Info

Publication number
SK9442001A3
SK9442001A3 SK944-2001A SK9442001A SK9442001A3 SK 9442001 A3 SK9442001 A3 SK 9442001A3 SK 9442001 A SK9442001 A SK 9442001A SK 9442001 A3 SK9442001 A3 SK 9442001A3
Authority
SK
Slovakia
Prior art keywords
group
formula
compounds
salts
physiologically acceptable
Prior art date
Application number
SK944-2001A
Other languages
English (en)
Slovak (sk)
Inventor
Werner Mederski
Horst Juraszyk
Hanns Wurziger
Christos Tsaklakidis
Dieter Dorsch
Sabine Bernotat-Danielowski
Guido Melzer
Soheila Anzali
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of SK9442001A3 publication Critical patent/SK9442001A3/sk

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
SK944-2001A 1999-01-08 1999-12-21 Imidazo[4,5-c]-pyridine-4-on-derivatives, process for the preparation thereof, use thereof and pharmaceutical composition comprising same SK9442001A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19900471A DE19900471A1 (de) 1999-01-08 1999-01-08 Imidazo[4,5c]-pyridin-4-on-derivate
PCT/EP1999/010236 WO2000040583A2 (de) 1999-01-08 1999-12-21 Imidazo[4,5-c]-pyridin-4-on-derivate

Publications (1)

Publication Number Publication Date
SK9442001A3 true SK9442001A3 (en) 2002-05-09

Family

ID=7893790

Family Applications (1)

Application Number Title Priority Date Filing Date
SK944-2001A SK9442001A3 (en) 1999-01-08 1999-12-21 Imidazo[4,5-c]-pyridine-4-on-derivatives, process for the preparation thereof, use thereof and pharmaceutical composition comprising same

Country Status (16)

Country Link
EP (1) EP1149099A2 (ja)
JP (1) JP2002534429A (ja)
KR (1) KR20010086085A (ja)
CN (1) CN1333772A (ja)
AR (1) AR022220A1 (ja)
AU (1) AU3041700A (ja)
BR (1) BR9916774A (ja)
CA (1) CA2357771A1 (ja)
CZ (1) CZ20012407A3 (ja)
DE (1) DE19900471A1 (ja)
HU (1) HUP0105054A3 (ja)
NO (1) NO20013384D0 (ja)
PL (1) PL349341A1 (ja)
SK (1) SK9442001A3 (ja)
WO (1) WO2000040583A2 (ja)
ZA (1) ZA200106454B (ja)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2232202T3 (es) 1998-12-23 2005-05-16 Bristol-Myers Squibb Pharma Company Heterobiciclos que contienen nitrogeno como inhibidores del factor xa.
AU2001268712A1 (en) * 2000-06-23 2002-01-08 Bristol-Myers Squibb Company 1 - (heteroaryl-phenyl) - condensed pyrazol derivatives as factor Xa inhibitors
CA2447488A1 (en) 2001-05-22 2002-11-28 Irina Jacobson Bicyclic inhibitors of factor xa
EP1569912B1 (en) 2002-12-03 2015-04-29 Pharmacyclics, Inc. 2-(2-hydroxybiphenyl-3-yl)-1h-benzoimidazole-5-carboxamidine derivatives as factor viia inhibitors
GB0215293D0 (en) 2002-07-03 2002-08-14 Rega Foundation Viral inhibitors
GB0225399D0 (en) * 2002-10-31 2002-12-11 Merck Sharp & Dohme Therapeutic agents
WO2005063744A2 (en) 2003-12-22 2005-07-14 K.U. Leuven Research & Development IMIDAZO[4,5-c]PYRIDINE COMPOUNDS AND METHODS OF ANTIVIRAL TREATMENT
SI1841765T1 (sl) 2004-12-21 2009-08-31 Gilead Sciences Inc Imidazo(4,5-c)piridinska spojina in postopek za antivirusno zdravljenje
WO2007009883A1 (en) * 2005-07-15 2007-01-25 F. Hoffmann-La Roche Ag Novel heteroaryl fused cyclic amines
US20070060530A1 (en) 2005-09-14 2007-03-15 Christopher Ronald J Administration of dipeptidyl peptidase inhibitors
US8222411B2 (en) 2005-09-16 2012-07-17 Takeda Pharmaceutical Company Limited Dipeptidyl peptidase inhibitors
WO2007112347A1 (en) 2006-03-28 2007-10-04 Takeda Pharmaceutical Company Limited Dipeptidyl peptidase inhibitors
KR101143596B1 (ko) 2006-07-07 2012-05-11 길리애드 사이언시즈, 인코포레이티드 신규의 피리다진 화합물 및 이의 용도
TW200838536A (en) 2006-11-29 2008-10-01 Takeda Pharmaceutical Polymorphs of succinate salt of 2-[6-(3-amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethy]-4-fluor-benzonitrile and methods of use therefor
UA99466C2 (en) 2007-07-06 2012-08-27 Гилиад Сайенсиз, Инк. Crystalline pyridazine compound
EP3180341B1 (en) * 2014-08-12 2022-04-27 Syngenta Participations AG Pesticidally active heterocyclic derivatives with sulphur containing substituents

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW219935B (ja) * 1991-12-25 1994-02-01 Mitsubishi Chemicals Co Ltd
JP2001524522A (ja) * 1997-12-01 2001-12-04 メルク エンド カムパニー インコーポレーテッド トロンビン阻害剤

Also Published As

Publication number Publication date
HUP0105054A3 (en) 2002-12-28
ZA200106454B (en) 2002-11-06
WO2000040583A3 (de) 2000-09-21
DE19900471A1 (de) 2000-07-13
JP2002534429A (ja) 2002-10-15
PL349341A1 (en) 2002-07-15
NO20013384L (no) 2001-07-06
WO2000040583A2 (de) 2000-07-13
EP1149099A2 (de) 2001-10-31
CZ20012407A3 (cs) 2001-12-12
CA2357771A1 (en) 2000-07-13
AU3041700A (en) 2000-07-24
NO20013384D0 (no) 2001-07-06
BR9916774A (pt) 2001-10-30
KR20010086085A (ko) 2001-09-07
AR022220A1 (es) 2002-09-04
CN1333772A (zh) 2002-01-30
HUP0105054A2 (hu) 2002-05-29

Similar Documents

Publication Publication Date Title
SK9442001A3 (en) Imidazo[4,5-c]-pyridine-4-on-derivatives, process for the preparation thereof, use thereof and pharmaceutical composition comprising same
AU752574B2 (en) Imidazo(4,5-C-)-pyridine-4-one derivatives with factor XA inhibiting effect
JP4624982B2 (ja) 血栓症の処置のための凝固因子Xa阻害剤としての1−N−(フェニル)−2−N−(フェニル)ピラゾリジン−1,2−ジカルボキサミド誘導体
KR20060023154A (ko) 혈전증 치료용 응고 인자 xa 및 viia의 저해제로서의피롤리딘-1,2-디카르복실산-1-[(4-에티닐-페닐)-아미드]-2-[(페닐)-아미드] 유도체
JP2004527514A (ja) フェニル誘導体3
SK12152001A3 (sk) Derivát pyrazol-3-ónu ako faktor Xa inhibítorov, spôsob jeho prípravy, jeho použitie a farmaceutický prostriedok, ktorý ho obsahuje
AU2002363366B2 (en) Derivatives of phenoxy-N- 4-(isothiazolidin-1,1-dioxid-2YL)pheny!-valerian- acid amide and other compounds as inhibitors of the coagulation factor XA in the treatment of thromboembolic diseases and tumors
JP4409941B2 (ja) 第Xa因子阻害剤としてのフェニル誘導体
JP4699985B2 (ja) カルボキサミド誘導体及びその第Xa因子の阻害剤としての使用
JP4567439B2 (ja) カルボン酸アミド
JP2005530754A (ja) 血栓塞栓症に有効なセミカルバジド誘導体
SK2652001A3 (en) 2-oxo-i(2h)-quinoline derivatives
JP2004525119A (ja) フェニル誘導体および血栓塞栓性疾患または腫瘍の処置におけるこれらの使用
MXPA01006942A (en) Imidazo[4,5-c]-pyridine-4-on-derivatives
KR20040095256A (ko) 세미카르바자이드 유도체 및 항혈전제로서의 이의 용도
CZ2001680A3 (cs) Derivát 2-oxo-2H-chinoIinu, způsob jeho přípravy, jeho použití a farmaceutický prostředek, který ho obsahuje
JP2004505106A (ja) アセトアミド誘導体並びに凝固第Xaおよび第VIIa因子の阻害剤としてのその使用
SK492004A3 (en) Carbohydrate derivatives